GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $34,000 | -46.0% | 21,476 | -29.7% | 0.00% | 0.0% |
| Q3 2015 | $63,000 | -6.0% | 30,566 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $67,000 | +2133.3% | 30,566 | +56503.7% | 0.00% | – |
| Q1 2015 | $3,000 | -99.5% | 54 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $596,000 | +6.4% | 139,805 | +28.1% | 0.01% | 0.0% |
| Q3 2014 | $560,000 | +4.1% | 109,105 | +33.1% | 0.01% | +9.1% |
| Q2 2014 | $538,000 | – | 81,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |